ISSCA Brasil 2026 | April 17–18, 2026 | Pullman São Paulo Vila Olímpia
São Paulo, Brazil — The International Society for Stem Cell Application (ISSCA) announces the International Congress in Regenerative Medicine – ISSCA Brasil 2026, taking place April 17–18, 2026, at the Pullman São Paulo Vila Olímpia. As one of the world’s most influential markets in aesthetics, wellness, and longevity medicine, Brazil continues to set global trends—and ISSCA’s arrival aims to reinforce this leadership through scientific education, international certification, and a collaborative platform for clinicians across Latin America.
In 2025, ISSCA hosted two major events in Brazil, with the second conference becoming one of the most successful gatherings of the entire year. This remarkable response from the Brazilian medical community has encouraged ISSCA to further expand its influence, bringing even more advanced scientific education, certifications, and global collaboration opportunities to São Paulo in 2026.
The two-day event will gather leading experts in cellular regeneration, aesthetics, metabolic health, peptide therapy, and longevity medicine to explore the clinical strategies and scientific innovations shaping the future of the field.
“Few countries influence global aesthetics and longevity medicine as powerfully as Brazil. ISSCA’s mission is to elevate that leadership through evidence-based training and international standards that reflect the future of regenerative science.”
— Benito Novas, Founder of ISSCA
A Scientific Program Tailored to One of the World’s Most Advanced Aesthetic Markets
ISSCA Brasil 2026 will offer a high-level scientific agenda designed for a country that stands at the forefront of aesthetic medicine, wellness innovation, and integrative patient care. Topics will include:
- Advanced regenerative medicine protocols
- Bioactive peptide applications for longevity, metabolism, and immune optimization
- Aesthetic tissue regeneration and facial optimization
- Exosome science and emerging biologics
- Musculoskeletal applications and pain modulation
- Integrative approaches to inflammation, aging, and hormonal balance
Highlighting national leadership, Dr. Márcio Kume (Brazil)—renowned for his expertise in musculoskeletal and cellular regenerative therapies—will join the ISSCA faculty, bringing a strong Brazilian voice to the global scientific dialogue.
Additional confirmed speakers include:
- Benito Novas (USA) — Global Strategic Leadership
- Andrea Lapeire (Argentina) — Regenerative Aesthetics & Longevity Protocols
- Lauren Fitzgerald (USA) — Peptide Therapy & Integrative Functional Medicine
More faculty members will be announced.
International Certifications Offered in Brazil
ISSCA will offer two internationally recognized certifications during the event:
1. ISSCA Flagship Certification in Regenerative Medicine
A structured, scientifically grounded program focused on cellular therapies, regenerative principles, protocols, and clinical application strategies. Ideal for physicians integrating modern regenerative treatments into their practice.
2. ISSCA Certification in Peptide Therapy
A specialized certification designed to prepare clinicians for the expanding field of peptide-based interventions, including metabolic optimization, immune modulation, performance medicine, and longevity strategies.
These certifications are especially valuable in Brazil’s rapidly evolving aesthetic and wellness sectors, where clinicians increasingly seek international validation and advanced scientific training.
MedConnect Brasil: A High-Level Networking Experience for Latin America’s Largest Medical Market
MedConnect Brasil will bring together the most influential practitioners in aesthetics, regenerative medicine, and longevity in a premium environment designed to foster strategic alliances and collaborative growth.
Through this exclusive networking platform, attendees will be able to:
- Connect with leading experts from Brazil, Latin America, Europe, and the USA
- Explore opportunities for clinical collaboration and research
- Exchange high-level insights on emerging technologies
- Strengthen their professional network within the region’s largest medical market
MedConnect reinforces ISSCA’s mission to create a global community of regenerative medicine professionals.
Why ISSCA’s Arrival Matters for Brazil
Following the extraordinary success of ISSCA’s two events in Brazil during 2025—particularly the second, which exceeded expectations in attendance, engagement, and scientific impact—the organization is committed to deepening its presence in the country. The rapid growth of Brazil’s regenerative medicine community highlights the need for continued international education, structured certification, and strategic alliances that support the next stage of the country’s medical evolution.
Brazil’s position as a global leader in aesthetics, longevity, and wellness creates a unique opportunity for regenerative medicine to thrive. However, rapid growth requires structure, safety, and international alignment.
ISSCA strengthens Brazil by:
- Providing globally validated certification programs
- Enhancing patient safety through standardized protocols
- Supporting clinicians with evidence-based training
- Integrating Brazil into a global scientific community
- Bridging innovation between Latin America, Europe, and the USA
- Accelerating the country’s standing as a regional hub for regenerative and longevity medicine
ISSCA Brasil 2026 is designed to empower clinicians, elevate standards, and amplify Brazil’s influence on the future of global regenerative medicine.
Call to Action: Registration Now Open
👉 Register Now at: https://issca.com
Early registration benefits include:
- Special Early-Bird pricing
- Priority access to certification programs
- Admission to MedConnect Brasil
- Pre-event educational materials and digital resources
About ISSCA
“The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.”
About Global Stem Cells Group
“Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.”
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business, partly based on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
